References
Khan SA, Schuetz S, Hosseini O. Primary-site local therapy for patients with de novo metastatic breast cancer: an educational review. Ann Surg Oncol. 2022;29:5811–20.
Soran A, Ozmen V, Ozbas S, et al. Randomized trial comparing resection of primary tumor with no surgery in stage IV breast cancer at presentation: Protocol MF07-01. Ann Surg Oncol. 2018;25:3141–9.
Khan SA, Zhao F, Goldstein LJ, et al. Early local therapy for the primary site in de novo stage IV breast cancer: results of a randomized clinical trial (EA2108). J Clin Oncol. 2022;2102006.
Soran A, Aytac O, Ozbas S. Locoregional therapy for intact primary tumor in de novo stage IV breast cancer. J Clin Oncol. 2022;2200802.
Khan SA, Zhao F, Goldstein L, et al. Reply to B. Ulas Kahya et al and A. Soran et al. J Clin Oncol. 2022;2200861.
Wang J, Tang H, Yin K, et al. Second invasive breast cancers in patients treated with breast-conserving therapy. Eur J Surg Oncol. 2021;47:2492–8.
Abraha I, Montedori A. Modified intention to treat reporting in randomised controlled trials: systematic review. BMJ. 2010;340:c2697.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Khan, S.A., Schuetz, S. & Hosseini, O. Reply to: "Impact of Primary-Site Local Therapy in Patients with De Novo Metastatic Breast Cancer," by Makris, Eleftherios et al.. Ann Surg Oncol 30, 1072–1073 (2023). https://doi.org/10.1245/s10434-022-12873-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-022-12873-7